We have 2 of 209 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.
This review proposes RDA as a conceptual framework for identifying ongoing, potentially modifiable disease processes in people receiving CFTR modulators and considers the implications of RDA for clinical research by identifying key evidence gaps and outlining a stepwise pathway for its definition and validation.